News Focus
News Focus
Followers 600
Posts 24109
Boards Moderated 3
Alias Born 12/06/2009

Re: None

Friday, 05/29/2020 8:21:23 AM

Friday, May 29, 2020 8:21:23 AM

Post# of 27661
Mymetics, Baylor College of Medicine to develop COVID-19 vaccine

Mymetics Corp. entered into a research collaboration with Baylor College of Medicine and Texas Children's Center for Vaccine Development to create a potential vaccine against COVID-19.

Under the agreement, Baylor will assess its recombinant protein-based SARS-CoV and SARS-CoV-2 antigens and combine them with Mymetics BV's virosomes, a vaccine carrier, to create a suitable vaccine.

Swiss biotech Mymetics aims to test a virosome-based vaccine candidate in humans within 12 months, the company said in a May 18 news release. Mymetics and Baylor are seeking additional funding for the clinical trials.

As of May 18, there have been over 4.7 million confirmed cases of COVID-19 worldwide, with over 315,700 deaths, according to data from Johns Hopkins University's Center for Systems Science and Engineering.

$MYMX

https://www.spglobal.com/marketintelligence/en/news-insights/blog/gauging-supply-chain-risk-in-volatile-times
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y